Atlas Trials

To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)

Clinical trial NCT05357677 · COMPLETED

Trial details

NCT number
NCT05357677
Sponsor
Shanghai SIMR Biotechnology Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postherpetic Neuralgia
Start date
2022-05-13
Primary completion
2023-01-13
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.